COVID-19 Medicine Update

COVID-19 Medicine Update: Restricted Emergency Use authorizations (EUA) for Medications in India

COVID-19 Medication, Drug Approvals, Medicinal Product Updates, Pharmacovigilance, Voluntary ADR reporting, , , , , , ,

The national regulatory body for Indian pharmaceuticals and medical devices- Central Drugs Standard Control Organisation (CDSCO) has provided approval as part of restricted & emergency use authorization for the below two medicines considering the unmet medical need for treatment of COVID-19 infected patients- Favipiravir Tablets for mild to moderate COVID-19 infection subject to various conditions…

Read More

USFDA’s Drug Safety Communication: Caution on COVID-19 medication

Drug Safety Updates, Pharmacovigilance, Safety Communications, , , , , ,

Food and Drug Administration (FDA) in the United States announced a serious safety concern on the use of hydroxychloroquine or chloroquine for the treatment of 2019 Coronavirus Disease (COVID-19) due to abnormal heart rhythms like QT prolongation and ventricular tachycardia. Currently, there are no medicines proven effective for the treatment of COVID-19. On 28‑Mar‑2020, FDA released…

Read More

error: Content is protected !!